Document is current
Any future updates will be listed below
-
Authors
Evers, Mitchell https://orcid.org/0000-0002-2940-5496
Stip, Marjolein
Keller, Kaylee
Willemen, Hanneke
Nederend, Maaike
Jansen, Marco
Chan, Chilam
Budding, Kevin
Nierkens, Stefan
Valerius, Thomas https://orcid.org/0000-0001-9181-8067
Meyer-Wentrup, Friederike
Eijkelkamp, Niels
Leusen, Jeanette https://orcid.org/0000-0003-4982-6914
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct01576692 at ClinicalTrials.govDocuments that mention this clinical trial
Initiation of immunotherapy with activated natural killer cells and anti-GD2 antibody dinutuximab prior to resection of primary neuroblastoma prolongs survival in mice
https://doi.org/10.1136/jitc-2020-001560
Anti-GD2 IgA kills tumors by neutrophils without antibody-associated pain in the preclinical treatment of high-risk neuroblastoma
https://doi.org/10.1136/jitc-2021-003163
-
Funding
Funding for this research was provided by:
KWF Kankerbestrijding (7650)
Vrienden van UMC Utrecht
Villa Joep (17)
DFG (Va124/9-1)
- License Information
